Supplements and Featured Publications
Novel Therapeutic Approaches to Target FGFR Mutations in Solid Tumors
The Current and Future State of Immune Checkpoint Inhibitors in NSCLC
The Emerging Landscape & Novel Biomarkers in Ovarian Cancer
Addressing the Unmet Needs in KRAS G12C–Mutated Solid Tumors
Priority Report: ASCO 2022: Updates in Genetic Testing
ASCO 2022 Meeting Reporter: Updates in Genitourinary Cancers
Milestones in Medicine: Premenopausal Patients With Breast Cancer and Fertility Preservation
Funding provided by TerSera Therapeutics LLC. Content independently developed by OncLive.
Research Efforts Underway for RARA+ MDS and AML
Diagnosis and Trial Options in Sarcoma
Novel Emerging Therapies in Relapsed/Refractory AML
Updates in Acute Graft-Vs-Host Disease
48th Annual Meeting of the EBMT
The 48th Annual Meeting of the EBMT meeting reporter is a publication encompassing the pivotal news presented during the conference, which spans clinical updates in hematologic malignancies.
Trop-2 Directed Antibody-Drug Conjugates for the Treatment of Solid Tumors
Evolving Approaches to ALL Treatment: CAR T-cell Therapy
The Evolving Approaches to ALL Treatment: CAR T-cell Therapy publication covers some of the latest practice-changing advances as it relates to emerging therapeutic strategies for patients with acute lymphoblastic leukemia.
Top 8 Trials From 2021 in Breast Cancer
The Top 2021 Abstracts in Breast Cancer publication provides expert insights on groundbreaking abstracts in breast cancer, with a focus on HER2-positive breast cancer treatment that were presented at medical meetings throughout 2021.
Sponsored in part by Daiichi Sankyo. Content independently developed by OncLive®
2022 Genitourinary Cancers Symposium
The 2022 Genitourinary Cancers Symposium publication includes articles and expert perspectives on the groundbreaking data presented at the 2022 Genitourinary Cancers Symposium in San Francisco, California.
Novel Targets in the Ovarian Cancer Treatment Paradigm
The Novel Targets in the Ovarian Cancer Treatment Paradigm publication covers some of the latest practice-changing advances as it relates to novel targets in the treatment for patients with advanced ovarian cancer.
Emerging Therapeutic Approaches to Target BRAF Mutations in Solid Tumors
The Emerging Therapeutic Approaches to Target BRAF Mutations in Solid Tumors publication covers some of the latest practice-changing advances as it relates to novel treatment strategies for patients with BRAF-mutated solid tumors.
SABCS 2021: Updates in HER2+ Breast Cancer
The SABCS 2021: Updates in HER2+ Breast Cancer publication provides expert insights on clinical news in HER2-positive breast cancer treatment from the 2021 San Antonio Breast Cancer Symposium.
Funding From Daiichi Sankyo/Content Developed Independently by OncLive
2021 ASH Annual Meeting: CAR T-Cell Therapy
The 2021 ASH Annual Meeting: CAR T-Cell Therapy priority report is a digital version of the print publication spanning some of the groundbreaking abstracts in CAR T-cell therapy that were presented during the conference.
2021 Year in Review: HER2+ Breast Cancer
The 2021 Year in Review: HER2+ Breast Cancer is the digital version of a print publication encompasses some of the biggest data that have read out in HER2-positive breast cancer in 2021, along with expert insights in article and video format.
My Treatment Approach: Advanced Ovarian Cancer
The My Treatment Approach: Advanced Ovarian Cancer publication covers some of the latest practice-changing advances in the treatment for patients with advanced ovarian cancer following recent regulatory decisions and data read outs from pivotal clinical trials, as well as expert insights on how they approach therapy on an individualized basis.
2021 Year in Review: Updates in Biomarker-Driven Lung Cancer
The 2021 Year in Review: Updates in Biomarker-Driven Lung Cancer is the digital version of a print publication encompasses some of the biggest data that have read out in bimarker-driven lung cancer in 2021, along with expert insights in article and video format.
Funding From Daiichi Sankyo/Content Developed Independently by OncLive
Updates in the Evolving Molecular Landscape of Head and Neck Squamous Cell Carcinomas
Diagnostic Challenges and Management of Desmoid Tumors
My Treatment Approach: Optimal Second- and Third-Line Treatment Options of cGVHD
The My Treatment Approach: Optimal Second- and Third-Line Treatment Options of cGVHD publication covers some of the latest and practice-changing advances in the treatment for patients with chronic graft-vs-host disease following recent regulatory decisions and data read outs from pivotal clinical trials, as well as expert insights on how they approach therapy on an individualized basis.
2021 ESMO Congress: Genitourinary Cancers
The 2021 ESMO Congress priority report focuses on updates in genitourinary cancers presented at the virtual conference, held September 16 to 21, 2021.
2021 ESMO Congress: Breast Cancer
The 2021 ESMO Congress priority report focuses on updates in breast cancer presented at the virtual conference, which was held September 16 to 21, 2021.
Therapeutic Updates in Myelofibrosis
This publication spans multiple updates regarding systemic treatment for patients with myelofibrosis, as well as expert insights in video format covering how they approach their patients with newly available agents.
My Treatment Approach: Colorectal Cancer
This publication covers some of the latest advances in colorectal cancer treatment following recent read outs from clinical trials, as well as expert insights on how they approach therapy on an individualized basis.